Glaucoma Risk Articles & Analysis: Older
6 news found
(Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today announced that the first patient has been treated in the novel TRIDENT clinical trial, designed to demonstrate the OMNI Surgical System with higher volume as a safe and effective standalone treatment option, compared to implantation of iStent ...
(Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of care and improve patients’ lives, today announced publication in Clinical Ophthalmology of favorable data showing that microinvasive glaucoma surgery (MIGS) using the OMNI® Surgical System suppressed daily fluctuations in intraocular pressure (IOP) ...
Ivantis, Inc., developer of the novel Hydrus® Microstent, a minimally invasive glaucoma surgery (MIGS) device designed to lower eye pressure for open-angle glaucoma patients, today announced that it has entered into an agreement with Glaukos Corporation to settle and dismiss all pending global litigation between them. ...
Injectsense’s first application is measurement of intraocular pressure (IOP), a glaucoma progression risk indicator. The IOP sensors, which have been tested in live animals, periodically send data to the cloud, providing physicians with clinically actionable information, keeping typically vulnerable glaucoma patients out of the ...
They struggle to cope with symptoms related to the eye’s inability to control the level of incoming light, including light sensitivity, glare, halos, reading difficulty, and problems with night driving. Many face above‐average risk of glaucoma and cataract formation as well. About VEO Ophthalmics Located in Cincinnati, Ohio, VEO Ophthalmics, LLC, is ...
They struggle to cope not only with the appearance of their eye, but also with symptoms related to the eye’s inability to control the level of incoming light, including light sensitivity, glare, halos, reading difficulty, and problems with night driving. Many face above-average risk of glaucoma and cataract formation as well. The CUSTOMFLEX ® ...